Dementia education required for clinicians

Summary#

B26-0862, the Dementia Readiness and Awareness in Continuing Education Amendment Act of 2026, would amend the District of Columbia Health Occupations Revision Act of 1985. Its stated goal is to improve health professionals’ knowledge of Alzheimer’s disease and related dementias; it would do so by requiring a one-time, one-hour continuing education course for certain clinicians. The bill has been introduced and referred to the Committee on Health, so it is not law.

  • Boards governing medicine, physician assistants, advanced practice registered nursing, registered nursing, and practical nursing would have to require the course for covered licensees.
  • It would apply to licensees who provide health care services to, and have direct patient interactions with, adult patients in a clinical setting in the District.
  • The course would need to cover the diagnosis, treatment, or care of people with Alzheimer’s disease and related dementias. It could be board-approved training or training offered or endorsed by a nationally recognized organization with expertise in dementia care.
  • Current licensees would have until the end of their first renewal period that begins after the law takes effect. People first licensed afterward would have until the end of their first renewal period after initial licensure.
  • The course hour could count toward the person’s other continuing education hours. The requirement would not apply to professionals who do not see adult patients in a District clinical setting, or who have completed qualifying training under a 2021 District law.

What it means for you#

  • Covered health professionals: You would need to complete the one-hour course once, by the deadline tied to your next renewal. The bill does not require you to take a separate hour on each of diagnosis, treatment, and care.
  • Licensing boards: Boards governing the five listed practices would have to add this requirement. They could approve courses, but the bill also allows qualifying training offered or endorsed by a nationally recognized organization with dementia-care expertise.
  • Patients and the public: The bill does not create a right to dementia screening, diagnosis, treatment, or other services. It requires education for certain clinicians, but does not guarantee a change in care.

Money#

No publicly available information on the bill’s costs is included in the supplied material.

  • The bill requires the relevant boards to impose the education requirement, but does not estimate staffing or administrative costs.
  • The bill says the Council adopts a fiscal impact statement in a committee report. That report was not supplied, so its estimate cannot be checked here.

What is unclear#

  • The existing Health Occupations Revision Act and the 2021 law cited for an exemption were not supplied. I could not verify current renewal rules or what training qualifies for that exemption.
  • The bill does not define terms such as “clinical setting” or “nationally recognized organization,” or explain how boards would verify course completion.
  • It does not set out a separate compliance process or penalty for failing to complete the course. How existing licensing rules would apply could not be verified without the current law.
  • The effective date depends on the bill becoming law and completing the approval and congressional-review steps described in the text; no calendar date is set.

Case for#

  • The sponsor’s letter says dementia is often not diagnosed and argues that early, accurate diagnosis can support better care. A required course is a direct way to put dementia education into continuing education for covered clinicians.
  • The letter points to changing research and treatment options. A course could help clinicians learn about current approaches to diagnosis, treatment, or care.
  • The requirement is limited to one hour once, and the hour can count toward other renewal education.

Case against#

  • A one-time hour may not keep clinicians’ knowledge current as research and treatment change. The bill does not require repeat training.
  • The bill does not specify course content beyond diagnosis, treatment, or care, or set a common standard for training from outside organizations. The amount and consistency of instruction could therefore vary.
  • The bill requires education but does not itself require screening, follow-up, or any particular change in clinical practice. The text does not show whether the course would improve diagnosis or care.
  • Boards would have to administer the requirement, but the supplied material does not show the cost or explain how completion would be checked.